Result card

  • EFF18: How does the use of FIT versus gFOBT for CRC screening technology modify the effectiveness of subsequent interventions?
English

How does the use of FIT versus gFOBT for CRC screening technology modify the effectiveness of subsequent interventions?

Authors: Jesús González-Enríquez, Francesca Gillespie, Stefania Lopatriello, Iñaki Imaz

Internal reviewers: Pseudo125 Pseudo125

Refer to domain search and domain methodology section.

We have not identified clinical trials or systematic reviews comparing FIT vs gFOBT in terms of the effectiveness of subsequent interventions (colonoscopy and surgery) in the context of population based colorectal cancer screening.  

 

Optional
Not
González-Enríquez J et al. Result Card EFF18 In: González-Enríquez J et al. Clinical Effectiveness In: Jefferson T, Cerbo M, Vicari N [eds.]. Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali; 2014. [cited 16 June 2021]. Available from: http://corehta.info/ViewCover.aspx?id=206